# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-015610
Filing Date
2025-04-25
Accepted
2025-04-25 09:00:45
Documents
23
Period of Report
2025-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20041194x1_def14a.htm iXBRL | DEF 14A | 991454
6 |  | logo_pmvpharma.jpg | GRAPHIC | 55635
7 |  | ny20041194x1_pc01.jpg | GRAPHIC | 603773
8 |  | ny20041194x1_pc02.jpg | GRAPHIC | 463375
9 |  | ny20041194x1_pvpchart01.jpg | GRAPHIC | 152896
10 |  | ny20041194x1_pvpchart02.jpg | GRAPHIC | 127733
11 |  | sig_davidhmack.jpg | GRAPHIC | 15618
12 |  | sig_robertticktin.jpg | GRAPHIC | 17857
| Complete submission text file | 0001140361-25-015610.txt |  | 5388996

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | pmvp-20250605.xsd | EX-101.SCH | 4017
3 | INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE | pmvp-20250605_def.xml | EX-101.DEF | 3124
4 | INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE | pmvp-20250605_lab.xml | EX-101.LAB | 7071
5 | INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE | pmvp-20250605_pre.xml | EX-101.PRE | 9094
25 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20041194x1_def14a_htm.xml | XML | 186762

Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39539 | Film No.: 25870182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)